Emphasis on Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, and Immunotherapy); End-Use (Hospitals, Clinics, Ambulatory Surgical Centers, and Others); and Region/Country
Glioblastoma Multiforme Treatment (GBM) market was valued at USD 2 billion in 2021 & is expected to grow at a CAGR of 8% from 2022-2030. The market for glioblastoma multiforme treatment market is witnessing growth mainly due to the development of new and innovative therapies to improve patient outcomes. Techniques such as the genetic mutation in the specific tumor cells are gaining popularity in the treatment of glioblastoma multiforme which is attributed to the growth of the market. For example, some tumors have mutations in the epidermal growth factor receptor (EGFR) gene, which can be targeted with drugs such as gefitinib and erlotinib. Further, increasing approvals of drugs for the treatment of glioblastoma multiforme is also a responsible factor for market growth of the glioblastoma treatment market. For instance, in June 2022, the FDA approved the two-drug combination dabrafenib and trametinib. These agents fall into the category of targeted therapies that attack cancer cells harboring BRAF mutations.
Some of the major players operating in the market include Merck & Co., Inc.; Amgen Inc.; F. Hoffmann-La Roche Ltd; Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Amneal Pharmaceuticals LLC; Karyopharm; Sumitomo Pharma Oncology, Inc; and Bristol-Myers Squibb Company Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst treatment, the chemotherapy segment is expected to grow with the highest CAGR during the forecast period.”
Based on treatment, the market is segmented into surgery, radiation therapy, chemotherapy, targeted therapy, tumor treating field (TTF) therapy, and immunotherapy. The chemotherapy segment is expected to grow with the highest CAGR during the forecast period. Chemotherapy involves the use of drugs to destroy cancer cells, and it is often used in combination with other treatments such as surgery and radiation therapy to improve the chances of success. The increasing incidence of brain tumors, the growing demand for personalized cancer treatment options, and the rising adoption of advanced chemotherapy drugs and delivery technologies are responsible for the growth of the segment.
“Amongst end-use, the direct sales segment held a dominant share in 2021”
Based on the end-use, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held a dominant share in 2021. The growth of the segment is driven by factors such as the increasing incidence of brain tumors, the growing demand for personalized cancer treatment options, and the rising adoption of advanced diagnostic and treatment technologies. Further, hospitals have world-class facilities and a wealth of expertise in treating GBM and other types of cancer, and they work closely with academic institutions and research organizations to develop new treatments and improve patient outcomes.
“Asia Pacific is expected to grow with the highest CAGR Glioblastoma Multiforme Treatment (GBM) market during the forecast period.”
The Asia Pacific is expected to grow with the highest CAGR glioblastoma multiforme treatment (GBM) market during the forecast period. This is mainly due to the presence of large and rapidly aging populations, and increasing incidence of brain tumors, including GBM. For instance, as per the Asian Development Bank, by 2050, one in four people in the Asia-Pacific region will be over the age of 60. The region’s elderly (over 60) population will triple between 2010 and 2050, reaching nearly 1.3 billion.
Glioblastoma Multiforme Treatment (GBM) Market Report Coverage
Reasons to buy this report:
Customization Options:
The global Glioblastoma Multiforme Treatment (GBM) market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Glioblastoma Multiforme Treatment (gbm) Market Covid-19 Impact
6. Global Glioblastoma Multiforme Treatment (gbm) Market Revenue, 2020-2028f
7. Market Insights By Treatment
8. Market Insights By End-use
9. Market Insights By Region
10. Glioblastoma Multiforme Treatment (gbm) Market Dynamics
11. Glioblastoma Multiforme Treatment (gbm) Market Opportunities
12. Glioblastoma Multiforme Treatment (gbm) Market Trends
13. Demand And Supply-side Analysis
14. Value Chain Analysis
15. Pricing Analysis
16. Strategic Insights
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Glioblastoma Multiforme Treatment (GBM) Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global glioblastoma multiforme treatment (GBM) market were the three major steps undertaken to create and analyze the adoption of glioblastoma multiforme treatment (GBM) in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of global glioblastoma multiforme treatment (GBM) market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the glioblastoma multiforme treatment (GBM) market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the glioblastoma multiforme treatment (GBM) market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as treatment and end-use. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the glioblastoma multiforme treatment (GBM) market. Further, we conducted factor analysis using dependent and independent variables such as intervention and distribution channel of the glioblastoma multiforme treatment (GBM) market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the glioblastoma multiforme treatment (GBM) market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global glioblastoma multiforme treatment (GBM) market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Glioblastoma Multiforme Treatment (GBM) market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the application and end-user in the global Glioblastoma Multiforme Treatment (GBM) market.
The main objective of the Global Glioblastoma Multiforme Treatment (GBM) Market Study
The current & future market trends of global glioblastoma multiforme treatment (GBM) market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
